Abstract
To date, much progress has been made in early-stage extranodal NK/T-cell lymphoma (ENKTCL), and risk-adapted therapy with radiotherapy (RT) alone for ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
